Literature DB >> 5596157

Nebramycin, a new broad-spectrum antibiotic complex. IV. In vitro and in vivo laboratory evaluation.

W E Wick, J S Welles.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5596157     DOI: 10.1128/AAC.7.3.341

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  24 in total

1.  A clinical study on the ototoxic effects of tobramycin.

Authors:  W Lehmann; R Häusler; F A Waldvogel
Journal:  Arch Otorhinolaryngol       Date:  1976-07-20

Review 2.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment.

Authors:  S R Westenfelder; G Welling; P O Madsen
Journal:  Infection       Date:  1974       Impact factor: 3.553

4.  The in-vitro activity of tobramycin compared with that of other aminoglycosides.

Authors:  P M Waterworth
Journal:  J Clin Pathol       Date:  1972-11       Impact factor: 3.411

5.  Tobramycin nephrotoxicity. A prospective clinical study.

Authors:  A Coca; J Blade; A Martinez; F Segura; E Soriano; M Ribas-Mundo
Journal:  Postgrad Med J       Date:  1979-11       Impact factor: 2.401

6.  Butirosin, a new aminoglycosidic antibiotic complex: antibacterial activity in vitro and in mice.

Authors:  C L Heifetz; M W Fisher; J A Chodubski; M O DeCarlo
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

7.  In vitro studies of tobramycin, an aminoglycoside antibiotic.

Authors:  J Dienstag; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

8.  Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.

Authors:  I B Ducan; J L Penner
Journal:  Can Med Assoc J       Date:  1975-07-12       Impact factor: 8.262

9.  Therapy of Pseudomonas aeruginosa infections with tobramycin.

Authors:  D C Blair; F R Fekety; B Bruce; J Silva; G Archer
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

10.  Comparison of the distribution of tobramycin and gentamicin in body fluids of dogs.

Authors:  J J Szwed; F C Luft; H R Black; R A Elliott; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.